Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo

Journal of Hepatology

Volumn 49, Issue 6, 2008, Pages 908-915

  Griffin, Stephen ^a   Trowbridge, Rachel ^a   Thommes, Pia ^b   Parry, Nigel ^b   Rowlands, David ^a   Harris, Mark ^a   Bright, Helen ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amantadine; Chimeric virus; GB virus B; Hepatitis C virus; p13; p7

Indexed keywords

AMANTADINE; ION CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHIMERA; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HEPATITIS C VIRUS P7; HEPATITIS GB VIRUS B; HUMAN; HUMAN CELL; IN VIVO STUDY; INFECTION; MARMOSET; NONHUMAN; PRIORITY JOURNAL; RNA EXTRACTION; VERO CELL; VIRION; VIRUS REPLICATION; VIRUS STRAIN;

AMANTADINE; ANIMALS; ANTIVIRAL AGENTS; CALLITHRIX; CELL LINE; DISEASE MODELS, ANIMAL; DRUG DESIGN; GB VIRUS B; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; KIDNEY; RECOMBINANT FUSION PROTEINS; RNA, VIRAL; TRANSFECTION; VIRAL PROTEINS;

EID: 55549103672     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.07.020     Document Type: Article

References (46)

1. Pawlotsky J.M. Therapy of hepatitis C: from empiricism to eradication. Hepatology 43 (2006) S207-S220
2. Pawlotsky J.M. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 7 (2003) 45-66
3. Mercer D.F., Schiller D.E., Elliott J.F., Douglas D.N., Hao C., Rinfret A., et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7 (2001) 927-933
4. Galun E., Burakova T., Ketzinel M., Lubin I., Shezen E., Kahana Y., et al. Hepatitis C virus viremia in SCID->BNX mouse chimera. J Infect Dis 172 (1995) 25-30
5. Ohba K., Mizokami M., Lau J.Y., Orito E., Ikeo K., and Gojobori T. Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatitis agents. FEBS Lett 378 (1996) 232-234
6. Muerhoff A.S., Leary T.P., Simons J.N., Pilot-Matias T.J., Dawson G.J., Erker J.C., et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 69 (1995) 5621-5630
7. Jacob J.R., Lin K.C., Tennant B.C., and Mansfield K.G. GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. J Gen Virol 85 (2004) 2525-2533
8. Lanford R.E., Chavez D., Notvall L., and Brasky K.M. Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. Virology 311 (2003) 72-80
9. Bukh J., Apgar C.L., Govindarajan S., and Purcell R.H. Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol 65 (2001) 694-697
10. Beames B., Chavez D., Guerra B., Notvall L., Brasky K.M., and Lanford R.E. Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus. J Virol 74 (2000) 11764-11772
11. Bright H., Carroll A.R., Watts P.A., and Fenton R.J. Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors. J Virol 78 (2004) 2062-2071
12. Beames B., Chavez D., and Lanford R.E. GB virus B as a model for hepatitis C virus. Ilar J 42 (2001) 152-160
13. Pletnev A.G., Bray M., Huggins J., and Lai C.J. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci USA 89 (1992) 10532-10536
14. Chambers T.J., Nestorowicz A., Mason P.W., and Rice C.M. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 73 (1999) 3095-3101
15. Rijnbrand R., Yang Y., Beales L., Bodola F., Goettge K., Cohen L., et al. A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. Hepatology 41 (2005) 986-994
16. Clarke D., Griffin S., Beales L., Gelais C.S., Burgess S., Harris M., et al. Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. J Biol Chem 281 (2006) 37057-37068
17. Griffin S.D., Harvey R., Clarke D.S., Barclay W.S., Harris M., and Rowlands D.J. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol 85 (2004) 451-461
18. Griffin S.D., Beales L.P., Clarke D.S., Worsfold O., Evans S.D., Jaeger J., et al. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 535 (2003) 34-38
19. Premkumar A., Wilson L., Ewart G.D., and Gage P.W. Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett 557 (2004) 99-103
20. Pavlovic D., Neville D.C., Argaud O., Blumberg B., Dwek R.A., Fischer W.B., et al. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci USA 100 (2003) 6104-6108
21. Sakai A., Claire M.S., Faulk K., Govindarajan S., Emerson S.U., Purcell R.H., et al. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci USA 100 (2003) 11646-11651
22. Carrere-Kremer S., Montpellier-Pala C., Cocquerel L., Wychowski C., Penin F., and Dubuisson J. Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. J Virol 76 (2002) 3720-3730
23. Griffin S., Clarke D., McCormick C., Rowlands D., and Harris M. Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes. J Virol 79 (2005) 15525-15536
24. Haqshenas G., Mackenzie J.M., Dong X., and Gowans E.J. Hepatitis C virus p7 protein is localized in the endoplasmic reticulum when it is encoded by a replication-competent genome. J Gen Virol 88 (2007) 134-142
25. Jones C.T., Murray C.L., Eastman D.K., Tassello J., and Rice C.M. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 81 (2007) 8374-8383
26. Steinmann E., Penin F., Kallis S., Patel A.H., Bartenschlager R., and Pietschmann T. Hepatitis C Virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog 3 (2007) e103
27. Ghibaudo D., Cohen L., Penin F., and Martin A. Characterization of GB virus B polyprotein processing reveals the existence of a novel 13-kDa protein with partial homology to hepatitis C virus p7 protein. J Biol Chem 279 (2004) 24965-24975
28. Takikawa S., Engle R.E., Emerson S.U., Purcell R.H., St Claire M., and Bukh J. Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein. Proc Natl Acad Sci USA 103 (2006) 3345-3350
29. Premkumar A., Dong X., Haqshenas G., Gage P.W., and Gowans E.J. Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication. Antiviral Ther 11 (2006) 289-295
30. Bukh J., Apgar C.L., and Yanagi M. Toward a surrogate model for hepatitis C virus: an infectious molecular clone of the GB virus-B hepatitis agent. Virology 262 (1999) 470-478
31. Yanagi M., St Claire M., Shapiro M., Emerson S.U., Purcell R.H., and Bukh J. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 244 (1998) 161-172
32. Hope R.G., Murphy D.J., and McLauchlan J. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J Biol Chem 277 (2002) 4261-4270
33. Targett-Adams P., Schaller T., Hope G., Lanford R.E., Lemon S.M., Martin A., et al. Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo. J Biol Chem 281 (2006) 29221-29227
34. Isherwood B.J., and Patel A.H. Analysis of the processing and transmembrane topology of the E2p7 protein of hepatitis C virus. J Gen Virol 86 (2005) 667-676
35. Carrere-Kremer S., Montpellier C., Lorenzo L., Brulin B., Cocquerel L., Belouzard S., et al. Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions. J Biol Chem 279 (2004) 41384-41392
36. Mizushima H., Hijikata M., Asabe S., Hirota M., Kimura K., and Shimotohno K. Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol 68 (1994) 6215-6222
37. Lin C., Lindenbach B.D., Pragai B.M., McCourt D.W., and Rice C.M. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol 68 (1994) 5063-5073
38. Haqshenas G., Dong X., Netter H., Torresi J., and Gowans E.J. A chimeric GB virus B encoding the hepatitis C virus hypervariable region 1 is infectious in vivo. J Gen Virol 88 (2007) 895-902
39. St. Gelais C., Tuthill T.J., Clarke D.S., Rowlands D.J., Harris M., and Griffin S. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system. Antiviral Res 76 (2007) 48-58
40. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., et al. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
41. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 (2005) 791-796
42. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102 (2005) 9294-9299
43. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103 (2006) 7408-7413
44. Yi M., Ma Y., Yates J., and Lemon S.M. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81 (2007) 629-638
45. Steinmann E., Whitfield T., Kallis S., Dwek R.A., Zitzmann N., Pietschmann T., et al. Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus. Hepatology 46 (2007) 330-338
46. Griffin S, St Gelais C, Owsianka A, Patel A, Rowlands D, Harris M. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology, 2008 in press.